Bio-Path Holdings is a biotechnology company developing therapeutic products for the liposomal delivery of nucleic acids in cancer patients.

Biotechnology

Health Care

Pharmaceutical

Therapeutics

Bio-Path Holdings

Bio-Path Holdings' headquarters in Houston, TX, United States

Peter Nielsen

Ana Tari Ashizawa

Anthony Price

Craig Hooper

Heath Cleaver

Douglas P. Morris

Jorge Cortes

Jason B. Fleming

Paul Aubert

The Advisory and Governance team at Bio-Path Holdings provides strategic guidance and oversight to ensure effective decision-making and compliance with regulatory requirements. Comprising experienced advisors, including a chairman, this team plays a crucial role in shaping the company’s direction, fostering collaborations, and enhancing corporate governance to support the development of innovative therapies for cancer patients.

Advisory and Governance

The Leadership Team at Bio-Path Holdings is responsible for strategic decision-making and overseeing the company's direction in the development of innovative therapeutic solutions. This includes managing research and clinical design initiatives, financial operations, and administrative functions to ensure the effective progression of liposomal delivery systems for cancer treatment. The team collaborates to align the company's goals with its mission of improving patient outcomes through advanced biotechnology.

Leadership Team

��

Bio-Path Holdings

Org chart

Board & advisors

Teams

Advisory and Governance

Leadership Team

Offices

��������

Bio-Path Holdings

Org chart

Board & advisors

Teams

Advisory and Governance

Leadership Team

Offices

Related companies

��